DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Heartland Advisors Inc.

Heartland Advisors Inc. grew its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 29.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 712,400 shares of the medical instruments supplier's stock after acquiring an additional 161,653 shares during the quarter. Heartland Advisors Inc. owned 0.36% of DENTSPLY SIRONA worth $13,521,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of XRAY. Natixis Advisors LLC grew its position in DENTSPLY SIRONA by 21.1% during the 3rd quarter. Natixis Advisors LLC now owns 21,733 shares of the medical instruments supplier's stock worth $588,000 after purchasing an additional 3,787 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of DENTSPLY SIRONA by 50.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier's stock valued at $55,900,000 after buying an additional 692,100 shares during the last quarter. Raymond James Trust N.A. increased its position in shares of DENTSPLY SIRONA by 37.7% in the 3rd quarter. Raymond James Trust N.A. now owns 13,299 shares of the medical instruments supplier's stock valued at $360,000 after acquiring an additional 3,641 shares during the period. Cerity Partners LLC acquired a new stake in DENTSPLY SIRONA during the 3rd quarter worth about $482,000. Finally, FMR LLC grew its stake in DENTSPLY SIRONA by 5.1% during the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier's stock valued at $245,076,000 after purchasing an additional 436,031 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

Remove Ads

DENTSPLY SIRONA Trading Down 0.3 %

NASDAQ:XRAY traded down $0.05 on Tuesday, reaching $14.89. The company's stock had a trading volume of 613,900 shares, compared to its average volume of 3,082,537. The firm has a market cap of $2.96 billion, a price-to-earnings ratio of -7.21, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $14.61 and a 12-month high of $33.22. The stock has a 50 day moving average price of $17.55 and a 200 day moving average price of $20.05.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.30%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.07%.

Insider Buying and Selling

In other news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.52% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Wells Fargo & Company decreased their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. Barrington Research decreased their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Mizuho reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Finally, UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research note on Tuesday, December 3rd. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.